Cargando…
Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442885/ https://www.ncbi.nlm.nih.gov/pubmed/32828129 http://dx.doi.org/10.1186/s13063-020-04697-1 |
| _version_ | 1783573523828047872 |
|---|---|
| author | Akram, Javed Azhar, Shehnoor Shahzad, Muhammad Latif, Waqas Khan, Khalid Saeed |
| author_facet | Akram, Javed Azhar, Shehnoor Shahzad, Muhammad Latif, Waqas Khan, Khalid Saeed |
| author_sort | Akram, Javed |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7442885 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74428852020-08-24 Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial Akram, Javed Azhar, Shehnoor Shahzad, Muhammad Latif, Waqas Khan, Khalid Saeed Trials Correction BioMed Central 2020-08-22 /pmc/articles/PMC7442885/ /pubmed/32828129 http://dx.doi.org/10.1186/s13063-020-04697-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Akram, Javed Azhar, Shehnoor Shahzad, Muhammad Latif, Waqas Khan, Khalid Saeed Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial |
| title | Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial |
| title_full | Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial |
| title_fullStr | Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial |
| title_full_unstemmed | Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial |
| title_short | Correction to: Pakistan Randomized and Observational Trial to Evaluate Coronavirus Treatment (PROTECT) of Hydroxychloroquine, Oseltamivir and Azithromycin to treat newly diagnosed patients with COVID-19 infection: A structured summary of a study protocol for a randomized controlled trial |
| title_sort | correction to: pakistan randomized and observational trial to evaluate coronavirus treatment (protect) of hydroxychloroquine, oseltamivir and azithromycin to treat newly diagnosed patients with covid-19 infection: a structured summary of a study protocol for a randomized controlled trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442885/ https://www.ncbi.nlm.nih.gov/pubmed/32828129 http://dx.doi.org/10.1186/s13063-020-04697-1 |
| work_keys_str_mv | AT akramjaved correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT azharshehnoor correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT shahzadmuhammad correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT latifwaqas correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial AT khankhalidsaeed correctiontopakistanrandomizedandobservationaltrialtoevaluatecoronavirustreatmentprotectofhydroxychloroquineoseltamivirandazithromycintotreatnewlydiagnosedpatientswithcovid19infectionastructuredsummaryofastudyprotocolforarandomizedcontrolledtrial |